We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Scientist in a lab coat holding a futuristic representation of medicine and genetics.
Industry Insight

Improving Genome Editing for Therapeutic Purposes

In this interview, John Finn tells us more about PGI, how it compares to other genome editing approaches and the benefits it could bring to genomic medicine discovery.
Human hand holding a variety of AI icons.
Industry Insight

The Ethical Implications of AI in Scientific Publishing

As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Blue and green DNA double helices on a purple background.
Industry Insight

Increasing Widespread Accessibility of Molecular Testing for Oncology Research

Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.
Blue representation of a male human showing ribcage and spine next to a DNA double helix.
Industry Insight

Shaping the Future of Genomic Medicine

In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
3 strands of DNA.
Industry Insight

Partnerships Provide Automated Library Preparation Solutions

We spoke to Amit Patel, product marketing director at PacBio, to learn more about PacBio Compatible, the new collaborations and what benefits they will bring to customers.
Newborn baby's feet.
Industry Insight

Revolutionizing Newborn Screening Through Next-Generation Sequencing

A recent study has shown the clinical value of proactive, sequencing-based screening in apparently healthy newborns for medically actionable conditions. How might these findings impact the current NBS landscape and what does it mean to the healthcare system on the global level?
Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Purple, blue, yellow, green and grey dots on a yellow background representing a microarray.
Industry Insight

The Staying Power of Chromosomal Microarray Analysis: Innovations on the Horizon Will Future Proof Tried and True Technology

Robert Balog describes innovations in microarray testing technology that are contributing to faster turnaround times, automated interpretation and improved coverage.
Close-up of a dog's snout.
Industry Insight

Man’s Best Friend – Solving the Dog Epigenome To Advance Human Oncology

This article discusses how the culture of canine-derived organoid lines can be used to make meaningful observations in the emerging field of comparative oncology, prompting the next revolution in animal and human cancer studies.
Illustration of DNA double helices with a flame pattern in the background.
Industry Insight

Gene Expression Analysis in Cancer Research

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
Advertisement